InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.57
(
0.18%
)
US TECH 100
19,210.00
(
-0.02%
)
Dow Jones
39,168.94
(
0.11%
)
Brent Oil
85.08
(
0.72%
)
Bitcoin
61,724.91
(
1.50%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: gpo344 post# 4319

Wednesday, 12/22/2010 7:58:32 PM

Wednesday, December 22, 2010 7:58:32 PM

Post# of 80490

but Gleevac is still very effective, and so are the others.


None of the currently approved drugs are effective against the T315I mutation and in CP pts who have failed at least 2 TKI's, Ponatinib has shown response rates equal to or exceeding any of the currently approved therapies.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up